Valeo Financial Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-497
Closed -$27K 1769
2021
Q1
$27K Sell
497
-198
-28% -$11.4K ﹤0.01% 1070
2020
Q4
$34K Buy
695
+100
+17% +$4.63K ﹤0.01% 904
2020
Q3
$19K Sell
595
-60
-9% -$1.91K ﹤0.01% 932
2020
Q2
$17K Sell
655
-400
-38% -$9.97K ﹤0.01% 1119
2020
Q1
$155K Buy
1,055
+291
+38% +$7.32K 0.02% 335
2019
Q4
$21K Buy
764
+500
+189% +$12.9K ﹤0.01% 917
2019
Q3
$6K Hold
264
﹤0.01% 1173
2019
Q2
$8K Sell
264
-8
-3% -$200 ﹤0.01% 1095
2019
Q1
$7K Buy
+272
New +$5.19K ﹤0.01% 1066

Other funds holding VCYT

Valeo Financial Advisors's VCYT Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 497 shares — an estimated $27K sold.

Valeo Financial Advisors first reported a position in VCYT in Q1 2019 and held it in 9 quarters. The position peaked at $155K in Q1 2020. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 497 Veracyte shares in Q2 2021, an estimated $27K.
  • Valeo Financial Advisors first reported a position in Veracyte in Q1 2019 and held it in 9 quarters.
  • Valeo Financial Advisors's Veracyte position peaked at $155K in Q1 2020.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.